Published in J Clin Microbiol on February 01, 1989
Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry. Clin Exp Immunol (2000) 1.13
Monoclonal antibody-based capture enzyme immunoassays for specific serum immunoglobulin G (IgG), IgA, and IgM antibodies to respiratory syncytial virus. J Clin Microbiol (1990) 1.13
Evaluation of immunoglobulin E-specific antibodies and viral antigens in nasopharyngeal secretions of children with respiratory syncytial virus infections. J Clin Microbiol (1993) 0.91
Tryptase and IgE concentrations in the respiratory tract of infants with acute bronchiolitis. Arch Dis Child (1995) 0.84
Cellular and humoral immunity of virus-induced asthma. Front Microbiol (2013) 0.81
Undetectable IgE responses after respiratory syncytial virus infection. Arch Dis Child (1996) 0.77
Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis (1985) 5.91
Two distinct subtypes of human respiratory syncytial virus. J Gen Virol (1985) 5.19
Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. J Immunol (1971) 3.33
Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine. J Clin Microbiol (1986) 2.43
Purification and characterization of the respiratory syncytial virus fusion protein. J Gen Virol (1985) 2.31
Purification and characterization of GP90, one of the envelope glycoproteins of respiratory syncytial virus. J Gen Virol (1984) 2.30
The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med (1981) 2.15
Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. J Clin Microbiol (1986) 2.09
Respiratory syncytial virus infection. Rapid diagnosis in children by use of indirect immunofluorescence. Am J Dis Child (1978) 1.90
Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection. J Clin Microbiol (1986) 1.79
Antibodies to respiratory syncytial virus polypeptides and their significance in human infection. J Gen Virol (1983) 1.58
Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus. J Infect Dis (1988) 1.52
Virus-specific IgE and IgG4 antibodies in serum of children infected with respiratory syncytial virus. J Pediatr (1987) 1.02
Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunization of lower alimentary tract with poliovaccine. J Immunol (1969) 3.49
Effect of tonsillectomy and adenoidectomy on nasopharyngeal antibody response to poliovirus. N Engl J Med (1971) 3.13
Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus. N Engl J Med (1971) 2.62
Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer. Oncogene (2000) 2.55
Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children. J Infect Dis (1990) 2.41
Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer. J Clin Oncol (1999) 2.38
Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease. JAMA (1985) 2.34
Local antibody response to poliovaccine in the human female genital tract. J Immunol (1973) 2.30
Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pediatr Res (1993) 2.22
Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann Oncol (2011) 2.18
The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med (1981) 2.15
Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol (1993) 2.01
Mechanism of action of camptothecin. Ann N Y Acad Sci (2000) 2.01
Intensity-modulated radiation therapy leads to survival benefit only in patients with high-risk prostate cancer: a population-based study. Ann Oncol (2014) 1.98
An improved spectrophotometric assay for superoxide dismutase based on epinephrine autoxidation. Anal Biochem (1978) 1.97
Antagonists agree on pesticide law reform. Science (1986) 1.95
Respiratory syncytial virus. Curr Probl Pediatr (1993) 1.93
Respiratory syncytial virus infection. Rapid diagnosis in children by use of indirect immunofluorescence. Am J Dis Child (1978) 1.90
Poliovirus antibody response in serum and nasal secretions following intranasal inoculation with inactivated poliovaccine. J Immunol (1969) 1.90
Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J Virol (1998) 1.88
Changes in nasopharyngeal flora during otitis media of childhood. Pediatr Infect Dis J (1990) 1.88
Potential spectrum of etiological agents of viral enteritis in hospitalized infants. J Clin Microbiol (1983) 1.85
Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis. J Infect Dis (2001) 1.78
Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States. JAMA (1973) 1.73
Effect of prior immunity on the shedding of virulent revertant virus in feces after oral immunization with live attenuated poliovirus vaccines. J Infect Dis (1991) 1.72
Trichomonas vaginalis and cervical cancer. A prospective study in China. Ann Epidemiol (1995) 1.71
Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J Pediatr (1992) 1.70
Immunologic aspects of human colostrum and milk. III. Fate and absorption of cellular and soluble components in the gastrointestinal tract of the newborn. J Immunol (1977) 1.69
STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6. J Biol Chem (1996) 1.68
The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses. J Pediatr (1980) 1.63
The neurogenetics of mucolipidosis type IV. Neurology (2002) 1.62
Detection of La Crosse arbovirus antigen in mosquito pools: application of chromogenic and fluorogenic enzyme immunoassay systems. J Clin Microbiol (1982) 1.62
Nasopharyngeal flora in the first three years of life in normal and otitis-prone children. Ann Otol Rhinol Laryngol (1991) 1.60
Capture immunoglobulin M system for rapid diagnosis of La Crosse (California encephalitis) virus infections. J Clin Microbiol (1982) 1.59
Adenocarcinomas of the esophagus and gastric cardia: the role of diet. Nutr Cancer (1997) 1.59
Otitis media in children. I. The systemic immune response to nontypable Hemophilus influenzae. J Infect Dis (1989) 1.55
Rubella-virus infection in juvenile rheumatoid arthritis. Lancet (1975) 1.52
Arthritis associated with induced rubella infection. J Immunol (1971) 1.51
Comprehensive analysis of 112 melanocytic skin lesions demonstrates microsatellite instability in melanomas and dysplastic nevi, but not in benign nevi. J Cutan Pathol (2001) 1.51
Extended pelvic lymph node dissection in prostate cancer: a 20-year audit in a single center. Ann Oncol (2013) 1.49
Improving energy expenditure estimation by using a triaxial accelerometer. J Appl Physiol (1985) (1997) 1.49
SUMO-1 conjugation to topoisomerase I: A possible repair response to topoisomerase-mediated DNA damage. Proc Natl Acad Sci U S A (2000) 1.47
Immunologic aspects of human colostrum and milk. II. Characteristics of lymphocyte reactivity and distribution of E-rosette forming cells at different times after the onset of lactation. J Pediatr (1978) 1.44
Antiviral effect of flavonoids on human viruses. J Med Virol (1985) 1.43
Aerobic fitness, not energy expenditure, influences subsequent increase in adiposity in black and white children. Pediatrics (2000) 1.43
Enzyme immunoassay with monoclonal antibodies for the detection of rotavirus in stool specimens. J Infect Dis (1985) 1.39
Evaluation of a neuraminidase-specific influenza A virus vaccine in children: antibody responses and effects on two successive outbreaks of natural infection. J Infect Dis (1979) 1.38
Imported monkey puzzle. Science (1990) 1.38
Induction of antibody response to Chlamydia trachomatis in the genital tract by oral immunization. Infect Immun (1991) 1.38
Adenocarcinomas of the esophagus and gastric cardia: medical conditions, tobacco, alcohol, and socioeconomic factors. Cancer Epidemiol Biomarkers Prev (1996) 1.37
Interleukin-1 alpha mediates the enhanced expression of intercellular adhesion molecule-1 in pulmonary epithelial cells infected with respiratory syncytial virus. Am J Respir Cell Mol Biol (1995) 1.36
Inducible translational regulation of the NF-IL6 transcription factor by respiratory syncytial virus infection in pulmonary epithelial cells. J Virol (1996) 1.35
Molecular luminescence studies of flavins. I. The excited states of flavins. J Am Chem Soc (1972) 1.35
Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease. Vaccine (1989) 1.35
Secretory antibody response to respiratory syncytial virus infection. Am J Dis Child (1981) 1.34
Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses. J Infect Dis (1990) 1.34
Clinical and immunologic evaluation of neuraminidase-specific influenza A virus vaccine in humans. J Infect Dis (1977) 1.33
c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells. Oncogene (2006) 1.33
Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors. Oncogene (2006) 1.32
Immunologic aspects of hepatitis-associated antigen and antibody in human body fluids. J Immunol (1973) 1.32
Isolation and characterization of two proteins from Moraxella catarrhalis that bear a common epitope. Infect Immun (1998) 1.32
Age-dependent rotavirus-enterocyte interactions. Proc Soc Exp Biol Med (1982) 1.31
Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells. J Infect Dis (1997) 1.31
Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through the induction of IFN-beta and IL-1 alpha. J Immunol (1996) 1.29
Patterns of physical activity in free-living adults in the Southern United States. Eur J Clin Nutr (2004) 1.29
Rotavirus infection of cultured intestinal epithelial cells induces secretion of CXC and CC chemokines. Gastroenterology (1998) 1.29
Nucleotide diversity in starch synthase IIa and validation of single nucleotide polymorphisms in relation to starch gelatinization temperature and other physicochemical properties in rice (Oryza sativa L.). Theor Appl Genet (2006) 1.28
The major component of IkappaBalpha proteolysis occurs independently of the proteasome pathway in respiratory syncytial virus-infected pulmonary epithelial cells. J Virol (1998) 1.28
Rapid diagnosis of parainfluenza virus infection in children. J Clin Microbiol (1982) 1.28
Persistent rotavirus infection in mice with severe combined immunodeficiency. J Virol (1987) 1.27
Extramucosal spread and development of hepatitis in immunodeficient and normal mice infected with rhesus rotavirus. J Virol (1990) 1.27
Irinotecan is an active agent in untreated patients with metastatic colorectal cancer. J Clin Oncol (1996) 1.27
Rapid detection of poliovirus by reverse transcription and polymerase chain amplification: application for differentiation between poliovirus and nonpoliovirus enteroviruses. J Clin Microbiol (1993) 1.26
Cigarette smoking and risk of clinical relapse in patients with Crohn's disease. Am J Prev Med (1990) 1.26
Post-therapy serum prostate-specific antigen level and survival in patients with androgen-independent prostate cancer. J Natl Cancer Inst (1999) 1.25
Snmp-1, a novel membrane protein of olfactory neurons of the silk moth Antheraea polyphemus with homology to the CD36 family of membrane proteins. J Biol Chem (1997) 1.24
Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees. J Immunol (1987) 1.23
Detection of eastern equine encephalomyelitis virus and Highlands J virus antigens within mosquito pools by enzyme immunoassay (EIA). II. Retrospective field test of the EIA. Am J Trop Med Hyg (1984) 1.23
Cell-mediated immune response to respiratory syncytial virus infection: relationship to the development of reactive airway disease. J Pediatr (1979) 1.23
Estimation of infection rates in population of organisms using pools of variable size. Am J Epidemiol (1980) 1.22
Characteristics of fusion of respiratory syncytial virus with HEp-2 cells as measured by R18 fluorescence dequenching assay. J Virol (1991) 1.22
Detection of eastern equine encephalomyelitis virus and Highlands J virus antigens within mosquito pools by enzyme immunoassay (EIA). I. A laboratory study. Am J Trop Med Hyg (1984) 1.21
Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitis. J Pediatr (1986) 1.21
Mechanism of mucosal immunity to viral infections in gammaA immunoglobulin-deficiency syndromes. Proc Soc Exp Biol Med (1974) 1.21
Distribution of rotavirus antigen in intestinal lymphoid tissues: potential role in development of the mucosal immune response to rotavirus. Clin Exp Immunol (1988) 1.20
Occurrence of respiratory syncytial virus subgroup A and B strains in Japan, 1980 to 1987. J Clin Microbiol (1988) 1.20
Treatment of Ménétrier's disease with a monoclonal antibody against the epidermal growth factor receptor. N Engl J Med (2000) 1.20
Defective regulation of immune responses in respiratory syncytial virus infection. J Immunol (1984) 1.20
In vitro correlates of cell-mediated immunity in human tonsils after natural or induced Rubella virus infection. J Infect Dis (1975) 1.20
Hatch batters NCI with straus case. Science (1981) 1.19
Strain-specific local and systemic cell-mediated immune responses to cytomegalovirus in humans. Infect Immun (1978) 1.18
Comparison of air-displacement plethysmography with hydrostatic weighing and bioelectrical impedance analysis for the assessment of body composition in healthy adults. Am J Clin Nutr (1999) 1.18
The role of dietary factors in the intestinal and diffuse histologic subtypes of gastric adenocarcinoma: a case-control study in the U.S. Cancer (1997) 1.17
Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China. Clin Genet (2010) 1.17